Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00844025|
Recruitment Status : Unknown
Verified March 2009 by Shin Kong Wu Ho-Su Memorial Hospital.
Recruitment status was: Enrolling by invitation
First Posted : February 13, 2009
Last Update Posted : March 31, 2009
|Condition or disease||Intervention/treatment||Phase|
|Elderly Chronic Disease||Behavioral: Pharmacist intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Care Provider, Outcomes Assessor)|
|Official Title:||Pharmaceutical Care and Clinical Outcomes for the Elderly Taking Potentially Inappropriate Medication: a Randomized-Controlled Trial|
|Study Start Date :||February 2009|
|Estimated Primary Completion Date :||February 2010|
|Estimated Study Completion Date :||February 2010|
Experimental: Pharmacist intervention
Patients in the intervention group will receive pharmaceutical care delivered by clinical pharmacist, which including medication review, medication reconciliation, patient education and recommended actions.
Behavioral: Pharmacist intervention
Medication review, medication reconciliation, and pharmacotherapy recommendation.
No Intervention: Usual care
Patients randomized to usual care group will receive routine review of medication by ward-based pharmacist and nurse.
- Number of unsolved drug-related problems [ Time Frame: 14 days after randomization ]
- Rate of adverse drug event during hospitalization [ Time Frame: 14 days after randomization ]
- Number of potentially inappropriate medication [ Time Frame: 14 days after randomization ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00844025
|Shin Kong Wo Ho-Su Memorial Hospital, Department of Pharmacy|
|Taipei, Taiwan, 111|
|Principal Investigator:||Liu Jen Wei, MS||Shin Kong Wo Ho-Su Memorial Hospital|